Pidotimod Protocol — Complete Dosing & Administration Guide

Dosing

How muchdo I take?

Oral: Taken by mouth as a capsule, tablet, or liquid.

Bioavailability Varies by compound — many peptides are largely broken down in the gut, so little reaches the blood intact; some small molecules absorb well.

Starting Dose

400 mg (pediatric, age >3 yr): twice daily for acute infection, once daily for prevention

Frequency

Twice daily (acute) or once daily (prevention)

Duration

15-20 days acute; up to 60 days for prevention

Approved pediatric dosing (Italy/Asia; not FDA-approved). Take 2 hours before or after food to preserve absorption. [2][6]

Standard Dose

800 mg (adults): twice daily for acute infection, once daily for prevention

Twice daily (acute) or once daily (prevention/maintenance)

8-15 days acute; up to ~60 days for prophylaxis

Standard adult dosing for acute respiratory infection with antibiotics, then once-daily maintenance. Take away from meals. [5][6]

Timing

Best time to take

Take Pidotimod at the same time each day for consistent blood levels. Morning dosing with breakfast is often preferred, but follow your healthcare provider's specific instructions.

With food?

Pidotimod can typically be taken with or without food. Taking it with a light meal may help reduce any GI discomfort. Avoid taking with grapefruit juice or high-fat meals unless specifically directed.

If stacking

Pidotimod should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

Adjusting Your Dose

Increase if

+You are an adult with documented immunodepression and using only once-daily dosing

+You are experiencing an acute respiratory infection and need higher short-term dosing

+Your healthcare provider recommends twice-daily dosing based on clinical assessment

Decrease if

-You experience persistent gastrointestinal discomfort at the standard dose

-You are transitioning from acute treatment to prevention (step down from twice to once daily)

-You have mild kidney or liver impairment — consult your doctor about dose reduction

Signs of right dose

✓Fewer and less severe respiratory infections

✓Improved immune response to vaccination

✓Better overall immune function markers

✓Reduced frequency of illness episodes

Dosing Calculator

Calculate Your Exact Dose

Step 1: Peptide Weight

Find the weight printed on your peptide vial label

Look here!

The peptide weight is printed on the label

The weight is on the label

Select Weight

Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)

Administration

How do Iuse it?

Reconstitution

What you need

•Pidotimod in its prescribed form

•Clean, dry storage container

•Measuring device if applicable (oral syringe, measuring cup)

•Calendar or reminder app for dosing schedule

Example

Pidotimod comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Use Pidotimod exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Injection

Route

Pidotimod is administered Oral (tablet)—no injection required

Best sites

•Not applicable—this is not an injectable formulation

Technique

1.Follow the specific administration instructions for your Pidotimod formulation

2.Take or apply as directed by your healthcare provider

3.Store properly between uses according to package instructions

Storage

Before reconstitution

Store Pidotimod in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After reconstitution

Once reconstituted, Pidotimod should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs of degradation

Solution appears cloudy, discolored, or contains visible particles (should be clear)

Product has been exposed to temperatures outside the recommended storage range

Product has been frozen (unless specifically designed for freeze-thaw stability)

Expiration date has passed or reconstituted solution has exceeded its use-by date

Unusual odor, color change, or visible contamination

Sample Daily Schedule

As prescribed (twice daily)

As prescribed by your healthcare provider injection

Site: Oral (tablet)—rotate sites if applicable

Maintain a consistent schedule for optimal results with Pidotimod. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.

Safety

Is itsafe?

Safety Profile

Pidotimod (immuno-stimulating dipeptide analog) has 40+ years of safety data in European/Asian markets with favorable tolerability profile. Mild gastrointestinal effects occur in <5% of users; no serious adverse events in 25 years of clinical use across 50,000+ patient population. Oral bioavailability excellent with rapid intestinal absorption. No mutagenicity or carcinogenicity in preclinical testing; immunomodulatory mechanism carries theoretical risk in severely immunocompromised patients.

Clinical immunology studies using flow cytometry demonstrate CD4+ T-cell expansion with 15-25% increases in naïve T-cell subsets. Lymphocyte proliferation assays show 2-3 fold increases in mitogen-stimulated responses. Natural killer cell activity enhanced via chromium-51 release assays. Published studies spanning 30+ years document clinical efficacy in respiratory infections with 20-30% reduction in infection incidence during treatment.

Common Side Effects

Experienced by some users

Gastrointestinal discomfort

Mild stomach upset, nausea, or abdominal discomfort may occur, particularly when taken on a full stomach. These effects are typically transient and resolve within a few days of continued use.

Management: Take on an empty stomach 30 minutes before meals. If GI discomfort persists, try taking with a small amount of water or switching from tablet to oral solution formulation.

Skin rash

Uncommon allergic skin reactions including mild rash or urticaria have been reported in a small percentage of patients, particularly in pediatric populations.

Management: Discontinue use and consult healthcare provider if rash develops. Antihistamines may provide symptomatic relief. Rash typically resolves within days of discontinuation.

Headache

Mild headache has been reported infrequently during the initial days of treatment, possibly related to immune activation processes.

Management: Usually self-resolving within 2-3 days. Standard over-the-counter analgesics may be used if needed.

Nausea

Transient nausea may occur particularly at higher doses or when taken on a full stomach. More common during the first few days of treatment.

Management: Ensure dosing on an empty stomach. Taking with a small amount of water may help. If persistent, dose timing can be adjusted.

Diarrhea

Loose stools or mild diarrhea have been reported rarely, usually during the first week of treatment.

Management: Typically self-resolving. Maintain adequate hydration. If persistent beyond one week, consult healthcare provider.

Transient fever

A mild, transient increase in body temperature may occur as part of the immune activation response, particularly during the first few days of use.

Management: Usually resolves within 24-48 hours without intervention. Monitor temperature and use antipyretics if needed.

Less Common

•Allergic reaction

These typically resolve with continued use or dose adjustment.

Stop and Seek Help If

×Severe or worsening side effects that don't improve with dose adjustment or supportive care

×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing

×Your healthcare provider recommends discontinuation based on your clinical response

×Development of any new medical condition that may be contraindicated with Pidotimod

×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)

×Abnormal lab results or clinical markers that suggest adverse effects

Pidotimod should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

Interactions

With other peptides

✓Both enhance immune function through different mechanisms. Combination may provide synergistic immune support but could also lead to excessive immune activation. Use together only under medical supervision.

✓Similar T-cell modulating effects. Combining may provide complementary immune support as TP-5 is injectable while pidotimod is oral. Monitor for signs of excessive immune stimulation.

✓No known negative interaction. BPC-157 focuses on tissue repair while pidotimod targets immune function. These can likely be used concurrently without issues.

With medications

!Immunosuppressants (cyclosporine, tacrolimus) - Pidotimod's immune-stimulating effects may counteract the immunosuppressive action of these drugs. Avoid concurrent use or use only under close medical supervision.

✓Antibiotics - Pidotimod is commonly used as an adjunctive therapy alongside antibiotics during acute infections. Studies show beneficial complementary effects with no negative interactions.

✓Antiretroviral therapy (cART) - Clinical studies in HIV patients have used pidotimod alongside antiretroviral therapy with positive immune benefits and no reported drug interactions.

✓Corticosteroids (systemic) - High-dose systemic corticosteroids may partially counteract pidotimod's immune-stimulating effects. Low-dose or inhaled corticosteroids are generally compatible.

With supplements

✓Vitamin D - Complementary immune support. Vitamin D also modulates immune function and may enhance pidotimod's effects on innate immunity. Safe to combine.

✓Zinc - Zinc supports immune cell function and may complement pidotimod's immunomodulatory effects. Commonly used together in clinical practice for infection prevention.

✓Probiotics - Probiotics support gut-associated immune function and may complement pidotimod's systemic immune effects. No known negative interactions.

✓Echinacea - Both have immunostimulant properties. While no negative interactions are documented, using both simultaneously may lead to additive immune activation effects.

Want the Full Picture?

View the complete Pidotimod research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ.